Therapeutic challenges for cisplatin-resistant ovarian germ cell tumors

The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant disease is challenging and prognosis remains poor. There are limited data on the efficacy of specific chemotherapeutic regimens, high-dose chemotherapy with autologous progenitor cell support and targeted therapies. The inclusion of patients in clinical trials is strongly recommended, especially in clinical trials on the most frequent male germ cell tumors, to offer wider therapeutic opportunities. Here, we provide an overview of current and potential new treatment options including combination chemotherapy, high-dose chemotherapy and molecular targeted therapies, for patients with cisplatin-resistant ovarian germ cell tumors

PARP inhibitors in endometrial cancer: current status and perspectives

Advanced, recurrent and metastatic endometrial cancer (EC) has a dismal prognosis due to poor response rates to conventional treatments. In the era of precision medicine, the improved understanding of cancer genetics and molecular biology has led to the development of targeted therapies, such as poly (ADP-ribose) polymerase (PARP) inhibitors. This class of drugs that inhibit PARP enzymes has been investigated in many different types of tumors and its use in the treatment of gynecological malignancies has rapidly increased over the past few years. Data from several clinical trials showed that PARP inhibitors have a beneficial role in cancers with a defect in the homologous DNA recombination system, regardless of the BRCA mutational status. Since EC frequently shows mutations in PTEN and TP53 genes, indirectly involved in the homologous DNA recombination pathway, several in vivo and in vitro studies investigated the efficacy of PARP inhibitors in EC, showing promising results. This review will discuss the use of PARP inhibitors in endome-trial cancer, summarizing data from preclinical studies and providing an overview of the ongoing trials, with a special focus on the development of combined treatment strategies with PARP inhibitors and immune checkpoint inhibitors

Air pollutants and daily number of admissions to psychiatric emergency services: evidence for detrimental mental health effects of ozone

Abstract Aims Aim of the current study is to investigate the associations between daily levels of air pollutants (particulate matter, ozone, carbon monoxide, nitrogen dioxide) and daily admissions for mental disorders to the emergency department of two general hospitals in Umbria region (Italy). Methods We collected data about daily admissions to psychiatric emergency services of two general hospitals, air pollutants' levels and meteorological data for the time period 1 January 2015 until 31 December 2016. We assessed the impact of an increase in air pollutants on the number of daily admissions using a time-series econometric framework. Results A total of 1860 emergency department admissions for mental disorders were identified. We observed a statistically significant impact of ozone levels on daily admissions. The estimated coefficient of O3 is statistically significant at the 1% level. All other pollutants were not significantly associated with the number of daily admissions. Conclusions Short-term exposure to ozone may be associated with increased psychiatric emergency services admissions. Findings add to previous literature on existing evidence for air pollution to have an impact on mental health. Ozone may be considered a potential environmental risk factor for impaired mental health

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study

Neutrophil-to-lymphocyte ratio (NLR) and systemic inflammatory index (SII) are prognostic factors in epithelial ovarian cancer (EOC). Their predictive value for platinum-sensitivity and their role in recurrent EOC are unknown. A total of 375 EOC patients were retrospectively analyzed. The correlation between baseline NLR and SII, and platinum-free interval (PFI) according to first line bevacizumab treatment were analyzed using logistic regression analyses adjusted for baseline patient characteristics. Subsequently NLR and SII calculated before second line treatment initiation were evaluated to identify a potential correlation with progression-free survival (PFS) and overall survival (OS) in platinum-sensitive and in platinum-resistant population. In multivariate analysis, NLR ≥ 3 is an independent predictive factor for PFI at 6 months in the chemotherapy group (OR = 2.77, 95% CI 1.38–5.56, p = 0.004), not in bevacizumab treated patients. After having adjusted for ECOG performance status, histology, ascites, bevacizumab treatment at second line and BRCA status, NLR ≥ 3 and SII ≥ 730 are significantly associated with worse OS in platinum-sensitive (HR = 2.69, 95% CI 1.60–4.53, p = 0.002; HR = 2.11, 95% CI 1.29–3.43, p = 0.003, respectively), not in platinum-resistant EOC patients. Low NLR is an independent predictive factor for platinum-sensitivity in patients treated without bevacizumab. NLR and SII are prognostic factors in recurrent platinum-sensitive EOC patients

Categorización del estado de conservación de los anfibios de la República Argentina

A más de una década de la primera Lista Roja de herpetofauna propuesta por la Asociación Herpetológica Argentina (Lavilla et al., 2000), se recategorizaron los anfibios a partir de nueva información taxonómica, biogeográfica, bio-ecológica y de modificaciones metodológicas respecto a la evaluación anterior. Mediante la participación de 35 especialistas de toda la Argentina se reevaluaron 175 taxones de anfibios (171 en la anterior) incluyendo 23 taxones nuevos para Argentina y obteniéndose como resultado la inclusión de 51 especies en la Lista Roja (8 En Peligro, 11 Amenazadas, 32 Vulnerables), 21 Insuficientemente Conocidas y 103 No Amenazadas. En relación con la categorización anterior de la AHA, los cambios de categorías han sido: un taxón descendió de las categorías En Peligro a Amenazado, siete taxones descendieron de Amenazados o Vulnerables a Insuficientemente Conocidos y nueve de Insuficientemente Conocidos a No Amenazados. Tres No Amenazados y 10 Insuficientemente Conocidos fueron elevados a distintas categorías de amenaza, nueve taxones Vulnerables fueron elevados a Amenazados, cinco de Vulnerables a En Peligro, y un taxón fue elevado de Amenazado a En Peligro. De 23 taxones no evaluados en el 2000, 16 se ubican en la categoría No Amenazados, tres en Insuficientemente Conocidos y cuatro en Vulnerables. Estas modificaciones son el resultado de: (1) mayor información sistemática, biogeográfica y bio-ecológica disponible para la evaluación,(2) cambios en cuanto a las presiones antrópicas sobre las especies o sus hábitats, (3) modificaciones metodológicas que incluyeron instructivos para aplicar los conceptos, la discusión y consenso entre especialistas y el análisis de las incertidumbres.More than a decade after the first red list of herpetofauna proposed by the Asociación Herpetológica Argentina (Lavilla et al., 2000), we recategorized amphibians based on new taxonomic, biogeographical, bio-ecological information and methodological changes in the former evaluation. Through the participation of 35 specialists from all over Argentina 175 taxa of amphibians (171 in the previous categorization) are reevaluated including 23 new taxa added to Argentina, obtaining as results the inclusion of 51 Red List species (8 Endangered, 11 Threatened, 32 Vulnerable), 21 Insufficiently Known and 103 Not Threatened. In relation to the former categorization of the AHA the changes were: one taxon descended from Critically Endangered to Endangered, seven taxa descended from Endangered orVulnerable to Insufficiently Known, and nine from Insufficiently Known to Not Threatened. Three Not Threatened and 10 Insufficiently Known were elevated to different categories of threat, nine taxa were elevated from Endangered to Vulnerable, five from Vulnerable to Endangered, and one from Threatened was elevated to Critically Endangered. Of 23 taxa not evaluated in 2000, 16 are placed as Not Threatened, three Vulnerable, and four Insufficiently Known. These changes are the result of: (1) more available information for evaluation from systematic, biogeography and bio- ecology, (2) changes in human pressures over the species or over their habitats, (3) methodological changes that included recommendations for applying concepts, discussion and consensus among experts and analysis of uncertainties.Asociación Herpetológica Argentin

REPAiR: REsource Management in Peri-urban AReas: Going Beyond Urban Metabolism: D8.1 Corporate Identity Guidelines

Version Final This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 688920.Environmental Technology and Desig

REPAiR: REsource Management in Peri-urban AReas: Going Beyond Urban Metabolism: D 8.6 Detailed Dissemination Plan and Dissemination Kit

The Detailed Dissemination Plan and Dissemination Kit is a strategic document for the beneficiaries helping them to establish the bases for their dissemination activities. It is a more detailed version of the Basic Dissemination Plan and Corporate Identity, deliverables of the REPAiR project D 8.3 and D 8.1,respectively. The general objective of this deliverable is to maximise the impacts of the results of REPAiR research project. There are four key audiences (main target groups) for this research, these are: (1) Researchers; (2) Decision and/or policy makers involved in European Circular Economy; (3) Non-governmental organisations and the general public; and (4) students. Dissemination activities of the REPAiR project are planned through well-targeted mechanisms through three main dissemination lines will be applied: (1) Internet communication – website (www.h2020repair.eu), social media, mailing list(s) and newsletter; (2) Publications – open access articles in leading peer-reviewed academic journals, press releases, features in printed press (and online media); (3) Events and Networks - national and international conferences, seminars and workshops, academic courses, practice-oriented workshops. All three lines will address the four key audiences. The effectiveness and success of REPAiR dissemination mechanisms are measured during the entire lifespan of the project. The Detailed Dissemination Plan is assumed to be a living document. It evolves and becomes more precise and substantial during the lifespan of the project, reflecting the steps undertaken to protect, exploit and disseminate the generated results. Therefore the Plan is presented in annex of the document.Version 1.4 This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 688920.Environmental Technology and Desig

Perinatal depression: A study of prevalence and of risk and protective factors

Background: International literature has shown that Postpartum Depression (PPD) has a significant social and relational impact on mothers and their partners, on the interaction between mother and child, as well as on the cognitive and emotional development of the child. The goal of this study is to increase the epidemiological knowledge of PPD and to evaluate both risk and protective factors. Subjects and methods: Our study is based on the administration of three tests, Paykel’s Life Events Scale, EPDS and MMPI-2, at three distinct time point (during the third trimester, 72 hours after delivery, and three months after delivery, respectively) to a sample of women recruited in the Prenatal Medicine Clinic at the Hospital of Perugia. The data collected was statistically analyzed. Results: The prevalence of PPD 72 hours after delivery was 11%, while the prevalence of PPD three months after delivery was 16.7%. Antepartum Depression (APD), measured using EPDS cut-offs scores of 9 and 14, was found to be a statistically significant risk factor for the development of PPD, while desired life-events during pregnancy can represent a protective factor. Conclusion: The prevalence of PPD that we measured, in agreement with that found in the literature, demonstrates that despite the fact that the diagnostic criteria of the DSM-IV refer to PPD only if it develops within 4 weeks after delivery, PPD can also develop after this period. Furthermore, it appears that monitoring APD and encouraging a psycho-socially serene pregnancy are important for prevention of PPD. In the case of APD it was shown that monitoring women with even light depressive symptoms is important, because these women are more likely to then develop PPD